Surgery and chemotherapy for intrahepatic cholangiocarcinoma

Table 1 Recent reported series of hepatectomy for intrahepatic cholangiocarcinoma

			Survival rate (%) and MST
Authors	Year	No	1-yr	3-yr	5-yr	MST (mo)	Significant prognostic factors for survival
Okabayashi	2001	60	68	35	29	19.6	Number of nodules, lymph-node involvement, vascular invasion, symptomatic tumor
Chen	1999	48	35.5	20.5	16.51
			27.2	8.8	7.82
DeOliveira	2007	44			40	28	Surgical margin
Palik	2008	97	74.9	51.8	31.1		Number of nodules, surgical margin
Inoue	2000	52	63	36	36	18	Surgical margin, lymph-node involvements, vascular invasion
Valverde	1999	30	86	22	22	28	Number of nodules, lymph-node involvements
Madariaga	1998	34	67	40	35	19	Number of nodules, surgical margin
Shimada	2007	94	69.5	35.5	31.1	24	Number of nodules, surgical margin, lymph-node involvements
Weber	2001	33		55	31	37.4	Vascular invasion

¹Data from intrahepatic cholangiocarcinoma patients with hepatolithiasis;

²Data from intrahepatic cholangiocarcinoma patients without hepatolithiasis; MST: Median survival time.